Association of Adenometous Polyposis Coli (APC) I1307K VariantPolymorphism with Colorectal Cancer among Selected Pakistani Population

Mehak Maryyam

doi:10.46243/jst.2022.v7.i02.pp77-86

Authors

Mehak Maryyam

DOI:

https://doi.org/10.46243/jst.2022.v7.i02.pp77-86

Abstract

Colorectal cancer is the result of abnormal growth of cells in colon and rectum. It is the major cause of mortality and morbidity globally. Among all cancer occurrence, CRC accounts for over 9%. In women, colorectal cancer is the seventh most common cancer and the ninth most common cancer in men, in Pakistan. Numerous risk factors are responsible for colorectal cancer, mainly age, smoking, alcohol consumption, family history and physical inactivity. Colorectal cancer due to genetic alterations occurs approximately with rate of 10% while sporadic colorectal cancer occurs with the rate of 90%. Adenomatous Polyposis Coli (APC) is a tumor suppressor gene and mutation in this gene downregulates the β-catenin which in turn activates the transcription of oncogenes. The objective of the present study is to analyze the significant association of APC I1307K (T→A) polymorphism with colorectal cancer in selected Pakistani population. This study includes 100 sporadic samples of CRC and 50 healthy controls. DNA was extracted from all CRC samples and controls. ARMS-PCR was performed to genotype APC I1307K polymorphism. Among three genotypes, TT, TA, AA, only two genotypes TT and TA were found in current study. Occurrence of APC I1307K was found to be significantly greater in CRC patients compared to controls (P-value 0.0000). Calculated allelic frequency of A allele was higher in patients (0.65%) than controls (0%). On the basis of significant statistical results, we may say that in our selected population, an association between APC I1307K variant and colorectal cancer was present.

References

Boyle P., Langman J.S., (2000) ABC of colorectal cancer: Epidemiology, BMJ; 321: 805–808

Grogan L., Kirsch I.R., (1997) Genetic testing for cancer risk assessment: a review, Oncologist; 2(4): 208–222

Weitz J., Koch M., Debus J., Hohler T., Galle P.R., Buchler M.W., (2005) Colorectal cancer, Lancet; 365: 153-165

Jeter J.M., Kohlmann W., Gruber S.B., (2006) Genetics of colorectal cancer, Oncology (Williston Park, N.Y.); 20(3): 269-76

Groden J., Thliveris A., Samowitz W., Carlson M., Gelbert L., Albertsen H., Joslyn G., Stevens J., Spirio L., Robertson M., (1991) Identification and characterization of the familial adenomatous polyposis coli gene, Cell 66(3): 589–600

Kwong L.N., Dove W.F., (2009) APC and its modifiers in colon cancer, Adv Exp Med Biol; 656: 85–106

Chen S.P., Tsai S.T., Jao S.W., Huang Y.L., Chao Y.C., Chen Y.L., Wu C.C., Lin S.Z., Harn H.J., (2006) Single nucleotide polymorphisms of the APC gene and colorectal cancer risk: a case-control study in Taiwan, BMC Cancer; 29: 83

Worm J., ChristensenC, Kirsten G., Tulchinsky E., Guldberg P., (2004) Oncogene, Nature; 23: 5215–5226

Lambertz S., Ballhausen W.G., (1993) Identification of an alternative 5’ untranslated region of the adenomatous polyposis coli gene, Hum. Genet; 90: 650-552

Hiltunen M.O., (1997) Hypermethylation of APC (adenomatous polyposis coli) promoter region in human colorectal carcinoma, Int. J. Cancer; 70: 644-648

Esteller M., (2000) Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer, Cancer. Res; 60, 4366-4371

Miyoshi Y., Nagase H., Ando H., Horii A., Ichii S., Nakatsuru S., (1992) Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene, Hum Mol Genet; 1: 229-33

Beroud C., Soussi T., (1996) APC gene: database of germline and somatic mutations in human tumors and cell lines, Nucleic Acids Res; 24: 121-124

Cottrell S., Bicknell D., Kaklamanis L., Bodmer W.F., (1992) Molecular analysis of APC mutations in familial adenomatous polyposis and sporadic colon carcinomas, Lancet; 340: 626-630

Powell S.M., (1992) APC mutations occur early during colorectal tumorigenesis, Nature; 359, 235-237

Gryfe R., Nicola N.D., Lal G., Gallinger S., Redston M., (1999) Inherited Colorectal Polyposis and Cancer Risk of the APC I1307K Polymorphism, Am. J. Hum. Genet; 64: 378–384

Liang J., Lin C., Hu F., Wang F., Zhu L., Yao X., Wang Y., Zhao Y., (2013) APC polymorphisms and the risk of colorectal neoplasia: a HuGE review and meta-analysis, Am J Epidemiol; 177(11):1169–1179

Kapitanovic S., Cacev T., Radosevic S., Spaventi S., Spaventi R., Pavelic K., (2004) APC gene loss of heterozygosity, mutations, E1317Q, and I1307K germ-line variants in sporadic colon cancer in Croatia, Exp Mol Pathol: 77: 193–200

Siegel R., Ma J., Zhaohui Z., Jemal A., (2014) Cancer statistics, CA Cancer J Clin.; 64: 9-29

Migliore.L, Migheli F., Spisni R., Coppede F., (2011) Genetics, cytogenetics, and epigenetics of colorectal cancer, J Biomed Biotechnol; 2011:792362

Frayling I.M., Beck N.E., Ilyas M., Dove E.I., Goodman P., Pack K., Bell J.A., Williams C.B., Hodgson S.V., Thomas H.J., Talbot I.C., Bodmer W.F., Tomlinson I.P., (1998) The APC variants I1307K and E1317Q are associated with colorectal tumors, but not always with a family history, Proc Natl Acad Sci USA; 95(18): 10722–10727

Malak A., Darwish H., Elsaid A., Tarapely F., Elshazli R., (2016) Association of APC I1307K and E1317Q polymorphisms with colorectal cancer among Egyptian subjects, Familial Cancer; 15: 49–56

Rennert G., Almog R., Lynn P.T., Low M., Pinchev M., Chaiter Y., Joseph D.B., Hedy S.R., Joel K.G., Stephen B.G., (2005) Colorectal Polyps in Carriers of the APC I1307K Polymorphism, Diseases of the Colon & Rectum; 48: 2317–2321

Rozen P., Shomrat R., Strul H., Naiman T., Karminsky N., Legum C., Orr-Utrtreger A., (1999) Prevalence of the I1307K APC gene variant in Israeli Jews of differing ethnic origin and risk for colorectal cancer, Gastroenterology; 116(1): 54-57

Drucker L., Shpilberg O., Neumann A., Shapira J., Stackievicz R., Beyth Y., Yarkoni S., (2000) Adenomatous polyposis coli I1307K mutation in Jewish patients with different ethnicity: prevalence and phenotype, Cancer; 88: 755–760

Laken S.J., Petersen G.M., Gruber S.B., Oddoux C., Oster H., Giardiello F.M., (1997) Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC, Nat Genet; 17: 79–83

Bougatef K., Marrakchi R., Ouerhani S., Sassi R., Moussa A., Kourda N., Blondeau L.Y., Najjar T., Ben J.S, Soubrier F., Ben A.E., (2009) No evidence of the PAC D1822V missense variant’s pathogenicity in Tunsian patients with sporadic colorectal cancer, Pathol Biol; 57(3):67-71

Evertsson S., Lindblom A., Sun X F., (2001) APC I1307K and E1317Q variants are rare or do not occur in Swedish colorectal cancer patients, Eur J Cancer; 37(4): 499-502

Zahoor A., Mansoor Q., Farooqi A.A., Fayyaz S., Naz G., Ismail M., (2015) Genetic variants in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and death receptor (DR4) genes contribute to susceptibility to colorectal cancer in Pakistani population, Cell.mol.Biol; 61(6): 108-112

Howlader N., Noone A.M., Krapcho M., (2013) SEER Cancer Statistics Review, 1975- 2010

Figer A., Shtoyerman C.R., Tamir A., Geva R., Irmin L., Flex D., Theodor L., Sulkes A., Sadetzki S., Meir B.S., Friedman E., (2001) Phenotypic characteristics of colo-rectal cancer in I1307K APC germline mutation carriers compared with sporadic cases, British Journal of Cancer; 85(9): 1368–1371 Table 1: Clinical and demographic characteristics of APC I1307K variant among the patients of colorectal cancer Table 2: APC I1307K genetic polymorphism among CRC patients